Evidence map›Paper›PMID 35264100›Full record

ArticleBMC infectious diseases2022

Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report.

Xiaoya Cui, Feifei Su, Hui Ye, Yi Jiang, Xiuxiu Guo

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. GastrointestinalFrontiers in immunology · 2022
    Pooled it
  2. Review
  3. DisseminatedFrontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaoya CuiDepartment of Infectious Diseases, Wenzhou Center Hospital, Wenzhou, 325000, Zhejiang Province, China. willabobby@163.com.ORCID http://orcid.org/0000-0002-5383-2113
Feifei SuDepartment of Infectious Diseases, Wenzhou Center Hospital, Wenzhou, 325000, Zhejiang Province, China.
Hui YeDepartment of Infectious Diseases, Wenzhou Center Hospital, Wenzhou, 325000, Zhejiang Province, China.
Yi JiangDepartment of Pathology, Wenzhou Center Hospital, Wenzhou, 325000, Zhejiang Province, China.
Xiuxiu GuoDepartment of Infectious Diseases, Wenzhou Center Hospital, Wenzhou, 325000, Zhejiang Province, China.
Wenzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastrointestinal involvement is not uncommon in patients with disseminated talaromycosis, but successful management of massive gastrointestinal bleeding and hemorrhagic shock secondary to talaromycosis is rarely reported. Clinical management strategies for these patients have not been well documented. CASE PRESENTATION: Here, we reported a case of disseminated talaromycosis with recurrent gastrointestinal bleeding and hemorrhagic shock who was successfully alleviated solely with medical treatment.

conclusionsEarly diagnosis and treatment for Talaromyces marneffei, intravenous fluid resuscitation, hemostatic therapy and blood transfusion are all essential for talaromycosis complicated with gastrointestinal bleeding and hemorrhagic shock. It is also necessary to warn about the possibility of bleeding induced or aggravated by endoscopic biopsy trauma.

Indexed as

MycosesShock, HemorrhagicEarly DiagnosisGastrointestinal HemorrhageHumansGastrointestinal hemorrhageHemorrhagic shockHuman immunodeficiency virusTalaromyces marneffei

Identifiers

PMID35264100
PMCPMC8905750
OpenAlexW4220801387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.